Results 11 to 20 of about 3,333,027 (254)

Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents [PDF]

International Journal of Hypertension
The lipid-based drug delivery system (LBDDS) is a well-established technique that is anticipated to bring about comprehensive transformations in the pharmaceutical field, impacting the management and administration of drugs, as well as treatment and ...
null Preeti, Sharda Sambhakar, Rohit Malik, Saurabh Bhatia, Ahmed Al Harrasi, Renu Saharan, Geeta Aggarwal, Suresh Kumar, Renu Sehrawat, Chanchal Rani   +9 more
doaj   +2 more sources

Transdermal Delivery of Antihypertensive Agents: A tabular update [PDF]

, 2011
Transdermal Drug Delivery System is viable drug delivery platform technology and has a strong market world wide. Transdermal Drug Delivery System is particularly desirable for drugs that need prolonged administration at controlled plasma level that basis
Jain, Ashish, Mishra, Anurag, Nayak, Satish, Soni, Vandana   +3 more
core   +3 more sources

Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky medication adherence scale [PDF]

, 2013
<b>Background and objectives</b> Poor adherence to medications is one of the major public health challenges. Only one-third of the population reported successful control of blood pressure, mostly caused by poor drug adherence.
AB Morris, AD Hyre, C Lenfant, CA Jackevicius, D. William Cameron, DE Morisky, DE Morisky, Donald E. Morisky, E Degli Esposti, E Yiannakopoulou, F Turnbull, G Levy, G Mancia, Gabrielle K. Y. Lee, GEC Wetzels, Harry H. X. Wang, HR Black, J Jin, K Wolf-Maier, Kirin Q. L. Liu, L Osterberg, LD Esposti, LG Ogden, M Burnier, M Krousel-Wood, M Krousel-Wood, Martin C. S. Wong, MC Wong, MCS Wong, MCS Wong, MCS Wong, MCS Wong, ME Inkster, O Friedman, P Lam, PJ McDonnell, PM Ho, PM Kearney, PS Wang, RB Haynes, S Svensson, SJ Billups, SY Zhang, TM Zyczynski, VL Champion, WC Cushman, WC Gerth, WJ Elliott, Yu Cheung   +48 more
core   +13 more sources

Effectiveness of antihypertensive agents in stage I/II hypertensive patients with ace (I/D) gene polymorphism

Journal of Medical and Scientific Research, 2023
Background: Angiotensin converting enzyme (ACE) is the key enzyme, regulates the blood pressure which is encoded by 21kb gene that consists of 26 exons and is located on chromosome 17, contains a polymorphism in the form of either Insertion (I) or ...
Bansal G, Chaithanya TM, Alam MA, Manchi RK   +3 more
doaj   +1 more source

Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials

Frontiers in Physiology, 2021
Background: Antihypertensive treatment may have different effects on central arterial hemodynamics. The extent of the difference in effects between various antihypertensive drugs remains undefined.Methods: We conducted a systematic review and meta ...
Yi-Bang Cheng, Jia-Hui Xia, Yan Li, Ji-Guang Wang   +3 more
doaj   +1 more source

Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network meta-analysis v1

protocols.io, 2020
Chronic hypertension complicates 3-5% of pregnancies, although the most appropriate antihypertensive treatment remains under investigation. The present network meta-analysis aims to accumulate current evidence in the field in order to compare the ...
I. Bellos, V. Pergialiotis, G. Daskalakis, D. Loutradis   +3 more
semanticscholar   +1 more source

Withdrawal of antihypertensive medication in young to middle-aged adults: a prospective, single-group, intervention study

Clinical Hypertension, 2023
Background Although antihypertensive drug therapy is commonly believed to be a life-long therapy, several recent guidelines have suggested that antihypertensive medications can be gradually reduced or discontinued for some patients whose blood pressure ...
Hae-Young Lee, Kyoung Suk Lee
doaj   +1 more source

Persistence and Adherence to Cardiovascular Medicines in Australia

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The burden of cardiovascular disease is increasing, with many people treated for multiple cardiovascular conditions. We examined persistence and adherence to medicines for cardiovascular disease treatment or prevention in Australia.
Juliana de Oliveira Costa, Jialing Lin, Sallie‐Anne Pearson, Nicholas A. Buckley, Andrea L. Schaffer, Michael O. Falster   +5 more
doaj   +1 more source

Impact of antihypertensive agents on clinical course and in-hospital mortality: analysis of 169 hypertensive patients hospitalized for COVID-19.

Revista da Associação Médica Brasileira, 2020
OBJECTIVE Coronavirus disease 2019 (COVID-19) is an emerging health threat caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-COV-2).
Í. Kocayiğit, H. Kocayiğit, S. Yaylacı, Y. Can, A. F. Erdem, O. Karabay   +5 more
semanticscholar   +1 more source

Drug interactions of antihypertensive agents

South African Family Practice, 2012
No abstract available.
L.H. Opie
doaj   +1 more source